Skip to main content
. 2019 Mar 4;9(3):e023453. doi: 10.1136/bmjopen-2018-023453

Figure 1.

Figure 1

An agent-based model of Neisseria gonorrhoea/Chlamydia trachomatis (NG/CT) and HIV cotransmission. The top panel represents the HIV care continuum and natural history: On infection with HIV, individuals serially progress through three disease stages over time; this progression can be halted by initiation of antiretroviral therapy (ART), which is assumed to result —if taken—in viral suppression within 4–24 weeks (see table 1).29 We assume, for simplicity, that engagement in care involves initiation of ART (as episodes of care engagement not resulting in ART initiation do not affect HIV transmission in the model). HIV-positive individuals in care are assumed to undergo regular screening for NG/CT (marked in red) subject to patients presenting for scheduled visits and clinician decision to screen. The bottom panel represents the natural history of NG/CT: infection may be symptomatic or asymptomatic, individuals remain infectious until diagnosis and treatment (which can occur either through symptomatic presentation to care or routine screening of asymptomatic individuals) or spontaneous resolution. On diagnosis with incident NG/CT, we assume that individuals are also screened for HIV infection (marked in yellow); if HIV-negative, we consider the possibility of PrEP delivery in this analysis. PrEP, pre-exposure prophylaxis.